NCT06402747View on ClinicalTrials.gov

Clopidogrel Versus Cilostazol on Vessels

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Type 2 DiabetesAtherosclerosis
Interventions
DRUG

Clopidogrel

Clopidogrel 75mg once daily

DRUG

Cilostazol

Cilostazol 200mg per day

Trial Locations (1)

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
collaborator

Samjin Pharmaceutical Co., Ltd.

INDUSTRY

lead

Seoul National University Bundang Hospital

OTHER